Astra falls 9% after Wainua misses primary endpoint in late-stage trial
Astra falls 9% after Wainua misses primary endpoint in late-stage trial
Astra falls 9% after Wainua misses primary endpoint in late-stage trial
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.